Pharmaceuticals
Japan's Eisai to invest in U.S. Alzheimer's blood testing firm C2N
Expanded use of tests could boost drugmaker's lecanemab medication
Pharmaceuticals
Pharmaceuticals
Sumitomo Pharma to cut 400 jobs at U.S. subsidiary
Move comes amid slow sales as company eyes net loss for second straight year
Retail
Japan drugstore chains join with Aeon to form world's fifth largest
Welcia and Tsuruha unite to expand in Asia and capture demand from aging population
Caixin
Chinese pharma turns to global deals to cure capital crunch
Sales of drug rights and M&A transactions help offset investment slump
International relations
U.S. and China to hold meeting on fentanyl this week
Talks in Beijing will cover precursor chemicals, senior American official says
Pharmaceuticals
Nikon bolsters drug research hubs in Japan and U.S.
Company looks to tap growth in regenerative medicine and gene therapy
Pharmaceuticals
Japan's Taisho Pharma to go private after successful tender offer
$4.8bn management buyout for drugmaker is the nation's largest ever
Politics
U.S. biotech Thermo Fisher halts DNA kit sales in Tibet
Concerns raised over sequencing technology sold to Chinese security authorities
Pharmaceuticals
Japan to speed up switch from prescription to over-the-counter drugs
Acid blockers and migraine treatments among medication not sold at stores
Pharmaceuticals
Eisai seeks expanded use of Alzheimer's drug for prevention
Leqembi in final trial as Japan drugmaker plans 2026 application for U.S. approval
Business deals
CVC Capital to buy Japan pharmacy operator Sogo Medical for $1.2bn
European fund aims to boost corporate value through expansion via acquisitions
Pharmaceuticals
Eisai-Biogen Alzheimer's therapy to cost about $20,000 per year in Japan
Price of highly-anticipated drug to largely be covered by public health insurance
Pharmaceuticals
Japan seeks more cutting-edge treatments with better drug price support
Changes aim to encourage foreign pharma startups to enter market
Business deals
Japan's Otsuka buys U.S. supplement maker Bonafide Health for $425m
Drugmaker aims to expand health food for women with its unit Pharmavite
Business deals
Japanese drugmaker Taisho eyes $5bn management buyout
Family of top shareholders eyes delisting for long-term turnaround as costs mount
Pharmaceuticals
Japan to allow nearly all over-the-counter drugs to be sold online
Ministry plans to end in-person rule for nonprescription medications as early as 2025
Health Care
Dengue fever sweeps through Asia, helped by hotter and wetter weather
More than 1,000 die in Bangladesh; major outbreak hits Taiwan
Pharmaceuticals
Japan to scrap rule requiring testing of new drugs on Japanese
Dropping slow process in early clinical trials would make medicines available sooner
Pharmaceuticals
Myopia eyedrops headed for clinical trials in Japan
Drug hoped to slow nearsightedness affecting 2bn people worldwide
Pharmaceuticals
Novartis sues Takeda in U.S. over trade secrets dispute
Swiss drugmaker says ex-employee hired by Japanese rival took confidential data
Caixin
China struggles to wean itself off bear bile farming
'Medical gold' alternative slow to emerge despite concern over extraction methods
Pharmaceuticals
Japan's Eisai to boost sales staff to focus on new Alzheimer's drug
Drugmaker to hire 40% more new grads following lecanemab approval in Japan, U.S.
Pharmaceuticals
Japan set to approve Alzheimer's drug Leqembi as soon as Monday
Eisai-Biogen treatment clears fast-track review after U.S. green light in August
Pharmaceuticals
Mitsui to expand health startup investment with focus on ASEAN
Trading house plans fivefold funding rise, sees technology as solution
Caixin
China's medical exports tumble as world moves on from COVID
Medicines and equipment hit by weak demand amid slow global recovery